Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 109,039 |
|
|||||
| News | - | ||||||
| Day High | 3.19 | Low High |
|||||
| Day Low | 2.925 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Gain Therapeutics Inc | GANX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.08 | 2.59% | 3.17 | 15:57:45 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.10 | 2.925 | 3.19 | 3.09 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 515 | 109,039 | $ 3.09 | $ 337,293 | - | 2.00 - 6.19 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:58:13 | 1 | $ 3.16 | USD |
Gain Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 40.15M | 12.91M | - | 55k | -22.11M | -1.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Gain Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GANX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.41 | 3.53 | 2.925 | 3.24 | 79,294 | -0.24 | -7.04% |
| 1 Month | 4.38 | 4.63 | 2.925 | 3.76 | 115,406 | -1.21 | -27.63% |
| 3 Months | 3.36 | 5.33 | 2.925 | 4.38 | 166,732 | -0.19 | -5.65% |
| 6 Months | 3.30 | 5.33 | 2.00 | 3.83 | 123,903 | -0.13 | -3.94% |
| 1 Year | 4.79 | 6.19 | 2.00 | 4.04 | 90,226 | -1.62 | -33.82% |
| 3 Years | 14.66 | 14.92 | 2.00 | 5.18 | 79,995 | -11.49 | -78.38% |
| 5 Years | 11.22 | 17.93 | 2.00 | 5.67 | 83,202 | -8.05 | -71.75% |
Gain Therapeutics Description
| Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements. |
